Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis-Reference-Cited by-同舟云学术

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis

Published:2021-04-12 Issue: Volume: Page:1-14
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Kadowaki Takashi¹,Yamamoto Fumiko²,Taneda Yusuke²,Naito Yusuke²^ORCID,Clark Douglas³,Lund Søren S.³,Okamura Tomoo²,Kaku Kohei⁴⁵^ORCID

Affiliation:

1. President, Toranomon Hospital, Tokyo, Japan

2. Medicine Division, Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan

3. TA CardioMetabolism Respiratory Med, Boehringer Ingelheim International GmbH, Ingelheim, Germany

4. General Internal Medicine, Kawasaki Medical School, Okayama, Japan

5. Faculty of Health and Welfare Services Management, Kawasaki University of Medical Welfare, Okayama, Japan

Funder

Nippon Boehringer Ingelheim Co. Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1898585

Reference87 articles.

1. International Diabetes Federation. IDF diabetes atlas. Brussels, Belgium: International Diabetes Federation; 2019. [cited 2020 Sep 30]. Available from: https://www.diabetesatlas.org/en/resources/.

2. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association

3. Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity

4. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

5. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat Metabolic Disorders to Maintain Health;Nutrients;2023-03-22

2. Adjusting the Use of Glucose-Lowering Agents in the Real-World Clinical Management of People with Type 2 Diabetes: A Narrative Review;Diabetes Therapy;2023-03-15

3. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review;World Journal of Diabetes;2022-12-15

4. Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes? a comparison between Asian versus White patients;Annals of Translational Medicine;2022-12

5. SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?;Polish Archives of Internal Medicine;2022-09-12